Heidelberg, Germany - BioMed X announced the launch of their first joint research project with Sanofi. As part of this, a new research group will be established at the BioMed X Institute in Heidelberg, Germany, that will focus on the development of a versatile computational platform able to accurately predict the efficacy of first-in-class drug candidates in virtual patient populations.

To apply for a group leader or a postdoc position, go here: [ Ссылка ].
Deadline: Sunday, January 8, 2022

свернуть